References
- Frenkel M. Safety of hydroxychloroquine. Arch Ophthalmol 1982; 100: 841
- Grant W M. Toxicology of the Eye. Charles C. Thomas, Springfield IllinoisUSA 1974; 270–9
- Karo T, Mäntyjärvi M. Eye complications caused by chloroquine in patients with rheumatoid arthritis. Acta Ophthalmol (Copenh) 1963; 41: 189
- Mackenzie A H. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983; 75(1A)40
- Ramsey M S., Fine B S. Chloroquine toxicity in the human eye. Am J Ophthalmol 1972; 73: 229
- Rosenthal A R., Kolb H, Bergsma D, Huxsoll D, Hopkins J L. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978; 17: 1158
- Rynes R I., Krohel G, Falbo A, Reinecke R D., Wolfe B, Bartholomew L E. Ophthalmologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum 1979; 22: 832
- Shearer R V., Dubois E L. Ocular changes induced by long-term hydroxychloroquine (Plaquenil) therapy. Am J Ophthalmol 1967; 64: 245
- Tobin D R., Krohel G B., Rynes R I. Hydroxychloroquine. Seven-year experience. Arch Ophthalmol 1982; 100: 81
- Voipio H. Incidence of chloroquine retinopathy. Acta Ophthalmol (Copenh) 1966; 44: 349